Jinyu Bio-technology Co., Ltd. (SHA:600201)
China · Delayed Price · Currency is CNY 12.18
0.00 (0.00%)
Jul 10, 2026, 3:00 PM CST
Jinyu Bio-technology Market Cap
Jinyu Bio-technology has a market cap or net worth of 13.31 billion as of July 10, 2026. Its market cap has increased by 56.36% in one year.
Market Cap
13.31B
Enterprise Value
12.09B
Revenue
1.39B
Ranking
n/a
PE Ratio
131.67
Stock Price
12.18
Market Cap Chart
Since January 18, 1999, Jinyu Bio-technology's market cap has increased from 977.52M to 13.31B, an increase of 1,261.56%. That is a compound annual growth rate of 9.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 13.31B | -19.18% |
| Dec 31, 2025 | 16.47B | 114.89% |
| Dec 31, 2024 | 7.66B | -34.56% |
| Dec 29, 2023 | 11.71B | 18.94% |
| Dec 30, 2022 | 9.85B | -46.16% |
| Dec 31, 2021 | 18.29B | -22.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 17.05B |
| Chengdu Olymvax Biopharmaceuticals | 15.97B |
| Anhui Anke Biotechnology (Group) | 13.60B |
| Mabwell (Shanghai) Bioscience | 13.39B |
| BrightGene Bio-Medical Technology | 13.02B |
| HitGen | 12.28B |
| InventisBio | 11.92B |
| Tibet Cheezheng Tibetan Medicine | 11.33B |